iRhythm Technologies $IRTC Shares Sold by Bessemer Group Inc.

Posted by Brenda Bartman on May 16th, 2026

Bessemer Group Inc. cut its holdings in iRhythm Technologies (NASDAQ:IRTC – Free Report) by 25.9% during the fourth quarter, HoldingsChannel reports. The firm owned 321,984 shares of the company’s stock after selling 112,251 shares during the period. Bessemer Group Inc.’s holdings in iRhythm Technologies were worth $57,132,000 as of its most recent filing with the SEC.

Other institutional investors also recently bought and sold shares of the company. Measured Wealth Private Client Group LLC acquired a new position in iRhythm Technologies in the third quarter valued at $30,000. Root Financial Partners LLC acquired a new position in iRhythm Technologies in the third quarter valued at $30,000. GAMMA Investing LLC increased its stake in iRhythm Technologies by 48.4% in the fourth quarter. GAMMA Investing LLC now owns 184 shares of the company’s stock valued at $33,000 after purchasing an additional 60 shares during the period. Smartleaf Asset Management LLC increased its stake in iRhythm Technologies by 100.0% in the third quarter. Smartleaf Asset Management LLC now owns 198 shares of the company’s stock valued at $34,000 after purchasing an additional 99 shares during the period. Finally, FNY Investment Advisers LLC acquired a new position in iRhythm Technologies in the third quarter valued at $34,000.

Analyst Upgrades and Downgrades

IRTC has been the topic of a number of recent research reports. Needham & Company LLC lifted their price objective on shares of iRhythm Technologies from $254.00 to $255.00 and gave the company a “buy” rating in a research note on Friday, May 1st. JPMorgan Chase & Co. dropped their price objective on shares of iRhythm Technologies from $215.00 to $175.00 and set an “overweight” rating on the stock in a research note on Friday, May 1st. Citigroup lifted their price objective on shares of iRhythm Technologies from $155.00 to $157.00 and gave the company a “buy” rating in a research note on Monday, May 4th. Wells Fargo & Company dropped their price target on shares of iRhythm Technologies from $200.00 to $180.00 and set an “overweight” rating on the stock in a research note on Friday, May 1st. Finally, Wall Street Zen upgraded shares of iRhythm Technologies from a “hold” rating to a “buy” rating in a research note on Sunday, May 3rd. Two research analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, iRhythm Technologies currently has an average rating of “Moderate Buy” and a consensus target price of $193.38.

Get Our Latest Report on IRTC

Insider Buying and Selling at iRhythm Technologies

In other news, CEO Quentin S. Blackford sold 25,540 shares of the business’s stock in a transaction dated Wednesday, February 25th. The shares were sold at an average price of $135.42, for a total transaction of $3,458,626.80. Following the transaction, the chief executive officer directly owned 186,126 shares in the company, valued at $25,205,182.92. The trade was a 12.07% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Chad Patterson sold 8,967 shares of the business’s stock in a transaction dated Wednesday, February 25th. The stock was sold at an average price of $135.42, for a total transaction of $1,214,311.14. Following the transaction, the insider owned 51,738 shares in the company, valued at approximately $7,006,359.96. This trade represents a 14.77% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 94,509 shares of company stock valued at $12,734,195. Insiders own 0.98% of the company’s stock.

iRhythm Technologies Trading Down 0.1%

Shares of iRhythm Technologies stock opened at $114.00 on Friday. iRhythm Technologies has a 52-week low of $112.31 and a 52-week high of $212.00. The company has a quick ratio of 4.98, a current ratio of 5.17 and a debt-to-equity ratio of 4.03. The company’s 50-day simple moving average is $119.69 and its 200-day simple moving average is $150.55. The firm has a market cap of $3.75 billion, a price-to-earnings ratio of -132.56 and a beta of 1.33.

iRhythm Technologies (NASDAQ:IRTC – Get Free Report) last issued its quarterly earnings results on Thursday, April 30th. The company reported ($0.35) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.56) by $0.21. iRhythm Technologies had a negative net margin of 3.53% and a negative return on equity of 10.26%. The business had revenue of $199.39 million for the quarter, compared to analyst estimates of $194.11 million. During the same period in the previous year, the business posted ($0.97) earnings per share. The business’s revenue was up 25.6% compared to the same quarter last year. As a group, equities research analysts anticipate that iRhythm Technologies will post 0.13 earnings per share for the current year.

About iRhythm Technologies

(Free Report)

iRhythm Technologies, Inc is a medical technology company that develops and commercializes wearable cardiac monitoring devices and associated data analytics services. Founded in 2006 and headquartered in San Francisco, California, the company’s flagship product is the Zio® patch, a discreet, single-use, continuous ECG recorder designed to monitor heart rhythms for up to 14 days. iRhythm’s digital diagnostics platform combines biosensor technology with proprietary algorithms to detect arrhythmias and streamline data interpretation for physicians.

The Zio service is prescribed by cardiologists and other healthcare providers to aid in the diagnosis of atrial fibrillation, bradycardia, tachycardia and other rhythm disorders.